Surgery Partners (NASDAQ:SGRY) Earns “Outperform” Rating from Royal Bank of Canada
Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They currently have a $35.00 price target on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 45.71% from the company’s […]
Surgery Partners (NASDAQ:SGRY – Get Free Report)‘s stock had its “outperform” rating restated by stock analysts at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They currently have a $35.00 price target on the stock. Royal Bank of Canada’s price target would suggest a potential upside of 45.71% from the company’s […]
